Blair William & CO Aeglea Bio Therapeutics, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.61 $4,724 - $9,938	-16,292 Reduced 21.27%	60,302 $17,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $85,365 - $205,363	24,390 Added 46.72%	76,594 $364,000
Q2 2020 Aug 12, 2020	BUY	$4.01 - $11.04 $100,250 - $276,000	25,000 Added 91.9%	52,204 $483,000
Q1 2018 May 15, 2018	BUY	$5.07 - $10.9 $81,120 - $174,400	16,000 Added 142.81%	27,204 $270,000
Q3 2017 Nov 13, 2017	BUY	$2.91 - $4.93 $32,603 - $55,235	11,204	11,204 $55,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.